immunotherapy

Immunotherapy News

A new immunotherapy, (CAR-T) treatment has been developed for advanced leukaemia in children and young adults where prior standard treatment has failed. Dr. Tim Cripe, a specialist oncologist at Nationwide Children’s Hospital in Ohio, described the experimental therapy CTL019 produced by Swiss pharma company Novartis as “the most exciting thing I’ve seen in my lifetime.”…